Clinical trial
Evaluation of the Role of Intravitreal Injection of TPA in Treatment of Refractory Diabetic Macular Edema
NCT01141881 is registered in ClinicalTrials.gov with Mashhad University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Role of Intravitreal Injection of TPA in Treatment of Refractory Diabetic Macular Edema
- Lead sponsor
- Mashhad University of Medical Sciences
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 31, 2009
- Completion date
- March 31, 2010
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema